Spec · Direct ListingBuilding next

Perpetual claim from day one

A Direct Listing is the listing path for individuals with a documented trajectory. No principal, no covenant period, no Phase 1 dividend stream. Just a perpetual e%e\%claim on the issuer’s lifetime Total Economic Benefit, live from day one. Five-plus years of attestable history is the baseline gate.

What a Direct Listing is

A Direct Listing is, mechanically, a Covenant Phase 2 without the Phase 1 that usually precedes it. Ten thousand ERC-20 tokens mint at listing; each carries a (e/N)(e/N)-fraction of the issuer’s future TEB, where ee is a committed share rate between 1% and 5% and N=10,000N = 10{,}000. Distributions flow quarterly. The token never expires.

The instrument suits people who aren’t raising capital but want price discovery, backer alignment, or eventually a liquidity event (established creators, post-exit founders, executive-track professionals, athletes) without giving up equity in any company.

Eligibility · the baseline gate

The review panel looks for four things:

CriterionMinimumWhy
Documented trajectory5+ years of attestable TEB (tax returns, W-2s, 1099s, K-1s)Backward signals in the conviction model need 3+ years to be meaningful; 5 is comfortable margin
Conviction score≥ 65Higher threshold than covenants (60) because Direct Listings skip the covenant-period observation window
Income diversificationHHI ≤ 0.60Single-stream income earners are re-routed to covenants. Power-law concentration requires runway to evaluate.
Regulatory clearabilityNo active SEC / FINRA sanctions, no pending material litigationCounsel-reviewed above $1M implied market cap

Review process · 4 – 12 weeks

  • 1.Application. Issuer submits attestable history, proposed ee, and narrative.
  • 2.TEB reconstruction. Preflop reconstructs 5-year TEB from the issuer’s tax filings. Issuer attests.
  • 3.Conviction scoring. Full 11-signal model with backward block weighted to 60%.
  • 4.Cap-check. Against any existing covenants on the same issuer (see cross-listing math).
  • 5.Counsel review. If implied market cap exceeds $1M, outside counsel sign-off on securities treatment under Reg D.
  • 6.Decision. Accept, counter-offer (lower ee or adjusted terms), or reject with named deficiencies.

Lockup · 2 – 8 weeks

Accepted listings enter lockup before tokens transfer. Lockup length scales with implied market cap: 2 weeks for listings under $500K, up to 8 weeks at $5M+. The lockup serves two purposes: orderly price discovery when the book opens, and a final window for material-event disclosure before trading begins.

Pricing · Gordon anchor, same as Phase 2

Direct Listings price via the pure-perpetuity collapse of the general pricing integral, identical in form to a post-T Covenant Phase 2 token:

Pref  =  1NeTEB0rgP_{\text{ref}} \;=\; \frac{1}{N} \cdot \frac{e \cdot \text{TEB}_0}{r - g}

Worked reference

Direct Listing with e=2%e = 2\%, TEB0=$500,000\text{TEB}_0 = \$500{,}000, r=12%r = 12\%, g=5%g = 5\%. Pref=$14.29P_{\text{ref}} = \$14.29 at CI ±30%.

See the pricing spec for the four-stage lifecycle.

Why the DL is the canonical fractional-equity instrument

For a Direct Listing parameterized as (e,[0,))(e, [0, \infty)), a single share rate ee over a window matching the VHCV_{\text{HC}} integration window. The effective equity rate collapses exactly:

eeff  =  VclaimVHC  =  eVHCVHC  =  e    exacte_{\text{eff}} \;=\; \frac{V_{\text{claim}}}{V_{\text{HC}}} \;=\; \frac{e \cdot V_{\text{HC}}}{V_{\text{HC}}} \;=\; e \;\;\text{exact}

No approximation, no piecewise integration, no forecast-dependence in the ratio. A 2% Direct Listing is a 2% fractional claim on the issuer’s lifetime human capital, full stop.

This makes the DL the canonical fractional-equity instrument on Preflop. The cleanest mapping from share rate to ownership fraction. Covenants approximate this with their two-phase structure; DLs nail it directly.

Dr. Amara Okafor at listing · Gordon idealization

Constant-growth Gordon forecast: TEB(0) = $2M, g=3%g = 3\% through year 10, gterm=2%g_{\text{term}} = 2\%.

VHCmid=$21.32MV_{\text{HC}}^{\text{mid}} = \$21.32\text{M}. DL at e=2%e = 2\%, so eeff=2.00%e_{\text{eff}} = 2.00\% exact.

MCap=0.02×$21.32M=$426,400\text{MCap} = 0.02 \times \$21.32\text{M} = \$426{,}400. Per token: $42.64\$42.64. Reserve at the 80% / low-band convention: Preserve$28.50P_{\text{reserve}} \approx \$28.50 (using VHClowV_{\text{HC}}^{\text{low}} ≈ $17.85M).

Engine cross-reference (v2.1.0)The Gordon idealization above (constant 3% growth then 2% terminal, single-stage closed form) illustrates the eeff = e collapse identity. The production Forecast Engine v2.1.0 runs the same Amara inputs through the medicine-surgical-private cohort (gaussian shape, τ=16\tau = 16 quarters) with 5 years of personal historicalTEB → wpersonal=0.50w_{\text{personal}} = 0.50, 6 of 15 adjustments fire (β ≈ 0.25), and produces a 5-segment piecewise growth schedule. Engine output: VHCmid$21.49MV_{\text{HC}}^{\text{mid}} \approx \$21.49\text{M}, per-token mid $42.99\$42.99 (low $22.73\$22.73, high $74.50\$74.50, CI 120%). The ~0.8% drift between the closed-form $21.32M and the engine’s $21.49M is intentional: established issuers with substantial personal data converge across forecast paths. See forecast-engine §Amara for the full piecewise walkthrough.

See the human-capital spec for the VHC and eeff identity, and the raise-mechanism spec for how the auction clears around the published reserve.

Cross-listing with existing covenants

A Direct Listing on an issuer who already has a Covenant must satisfy the 25% TEB cap invariant at every point in time. The cap-check runs both algorithms from the cross-listing math spec before the listing is approved.

Worked cross-listing

Issuer has a s=5%, T=7, ecov=2% covenant at year 3. New Direct Listing at edir=3%.

Years 3–7 total utilization: 5% + 3% = 8%. Years 7+: 2% + 3% = 5%. Under 25% at every point → accepted. The two listings trade independently; at year 7, covenant tokens transition to Phase 2 and become economically equivalent to the Direct Listing class.

Direct Listing vs. Covenant · which is which

DimensionCovenantDirect Listing
Capital at listingYes (principal R)No (Flow A default). Flow C = deferred liquidity on reserved block.
Best forPre-seed founders; early-career creators5+ year documented trajectory; post-exit founders, established creators
Phase 1 dividend stream?Yes (years 1 – T)No
Phase 2 perpetuity?Yes (year T+)Yes (day 1)
Review length2 – 4 weeks4 – 12 weeks
LockupMultiple triggers (data + conviction + funding)Fixed 2 – 8 weeks
Conviction gate≥ 60≥ 65

Related specs